相关实验视频

Updated: Jul 10, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

在轻度认知障碍患者的血液中探索循环的长非编码RNA

Bruna De Felice¹, Cinzia Coppola², Simona Bonavita²

¹Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Università degli Studi della Campania "Luigi Vanvitelli", Via G. Vivaldi 42, 81100 Caserta, Italy.

|November 25, 2023

概括

这项研究确定了轻度认知障碍 (MCI) 患者血液中的新型长非编码RNA (lncRNA) 表达模式. 这些发现揭示了MCI病原和向痴呆症进展的潜在RNA生物标志物.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

轻度认知障碍 (MCI) 是痴呆症的前体,记忆缓解性MCI对阿尔茨海默病进展的风险很高.
脑损伤和阿尔茨海默病是复杂的疾病,受复杂的分子和生物相互作用的影响.
非编码RNAs,特别是长非编码RNAs (lncRNAs),是基因表达的关键调节者,并有助于细胞调节网络.

研究的目的:

为了研究MCI患者血液中特定lncRNAs (SNHG16,H19,NEAT1) 的表达模式.
确定与lncRNA相关的microRNA (miRNA) 调节轴与MCI有关.
探索RNA交叉交谈在MCI遗传倾向和病理生理学中的作用.

主要方法:

微阵列分析用于比较来自MCI患者和健康对照者的血液样本中的IncRNA表达特征.
该研究的重点是确定失调的lncRNA及其与miRNA的潜在调节相互作用.
这项研究代表了从轻度认知障碍患者的血液样本中首次探索lncRNA配置文件.

主要成果:

与对照组相比,在MCI患者的血液中观察到特定长非编码RNA的表达显著改变.
该研究确定了与MCI有关的潜在lncRNA-miRNA调节轴.
这些发现突显了lncRNAs作为MCI生物标志物的潜力.

结论:

已确定的lncRNA表达模式和调节轴为MCI背后的分子机制提供了新的见解.
这项研究提出了新的RNA标,涉及到轻度认知障碍的病变发生.
这些发现有助于理解参与MCI倾向和进展的遗传因素,可能有助于早期诊断和治疗策略.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.H19 H19 是一种H19病毒.在MCI中,MCI是MCI.在NEAT1中,NEAT1是NEEAT1的类型.在SNHG16中,SNHG16是SNHG16中的一个.在 lncRNAs 中.轻度的认知障碍轻度的认知障碍

更多相关视频

Identification of Circular RNAs using RNA Sequencing

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...